Crescent Biopharma Inc

CUSIP: 38000Q201 Class: COM

Holders for Q4 2025 Position Changes for Q4 2025

Note: Option positions (PUT/CALL) are excluded.

InstitutionSharesValue ($000)
Remedium Capital Partners, LLC361,250$4
Quadrature Capital Ltd13,246$157
Total (2 institutions)374,496$161